AIMS/HYPOTHESIS: The aim of this work was to investigate whether measurement of the mean common carotid intima-media thickness (CIMT) improves cardiovascular risk prediction in individuals with diabetes. METHODS: We performed a subanalysis among 4,220 individuals with diabetes in a large ongoing individual participant data meta-analysis involving 56,194 subjects from 17 population-based cohorts worldwide. We first refitted the risk factors of the Framingham heart risk score on the individuals without previous cardiovascular disease (baseline model) and then expanded this model with the mean common CIMT (CIMT model). The absolute 10 year risk for developing a myocardial infarction or stroke was estimated from both models. In individuals with diabetes we compared discrimination and calibration of the two models. Reclassification of individuals with diabetes was based on allocation to another cardiovascular risk category when mean common CIMT was added. RESULTS: During a median follow-up of 8.7 years, 684 first-time cardiovascular events occurred among the population with diabetes. The C statistic was 0.67 for the Framingham model and 0.68 for the CIMT model. The absolute 10 year risk for developing a myocardial infarction or stroke was 16% in both models. There was no net reclassification improvement with the addition of mean common CIMT (1.7%; 95% CI -1.8, 3.8). There were no differences in the results between men and women. CONCLUSIONS/ INTERPRETATION: There is no improvement in risk prediction in individuals with diabetes when measurement of the mean common CIMT is added to the Framingham risk score. Therefore, this measurement is not recommended for improving individual cardiovascular risk stratification in individuals with diabetes.
AIMS/HYPOTHESIS: The aim of this work was to investigate whether measurement of the mean common carotid intima-media thickness (CIMT) improves cardiovascular risk prediction in individuals with diabetes. METHODS: We performed a subanalysis among 4,220 individuals with diabetes in a large ongoing individual participant data meta-analysis involving 56,194 subjects from 17 population-based cohorts worldwide. We first refitted the risk factors of the Framingham heart risk score on the individuals without previous cardiovascular disease (baseline model) and then expanded this model with the mean common CIMT (CIMT model). The absolute 10 year risk for developing a myocardial infarction or stroke was estimated from both models. In individuals with diabetes we compared discrimination and calibration of the two models. Reclassification of individuals with diabetes was based on allocation to another cardiovascular risk category when mean common CIMT was added. RESULTS: During a median follow-up of 8.7 years, 684 first-time cardiovascular events occurred among the population with diabetes. The C statistic was 0.67 for the Framingham model and 0.68 for the CIMT model. The absolute 10 year risk for developing a myocardial infarction or stroke was 16% in both models. There was no net reclassification improvement with the addition of mean common CIMT (1.7%; 95% CI -1.8, 3.8). There were no differences in the results between men and women. CONCLUSIONS/ INTERPRETATION: There is no improvement in risk prediction in individuals with diabetes when measurement of the mean common CIMT is added to the Framingham risk score. Therefore, this measurement is not recommended for improving individual cardiovascular risk stratification in individuals with diabetes.
Authors: Yasmine S Ali; Karen E Rembold; Brad Weaver; Mary Beth Wills; Steven Tatar; Carlos R Ayers; Christopher M Rembold Journal: Atherosclerosis Date: 2005-10-17 Impact factor: 5.162
Authors: Hester M Den Ruijter; Sanne A E Peters; Todd J Anderson; Annie R Britton; Jacqueline M Dekker; Marinus J Eijkemans; Gunnar Engström; Gregory W Evans; Jacqueline de Graaf; Diederick E Grobbee; Bo Hedblad; Albert Hofman; Suzanne Holewijn; Ai Ikeda; Maryam Kavousi; Kazuo Kitagawa; Akihiko Kitamura; Hendrik Koffijberg; Eva M Lonn; Matthias W Lorenz; Ellisiv B Mathiesen; Giel Nijpels; Shuhei Okazaki; Daniel H O'Leary; Joseph F Polak; Jackie F Price; Christine Robertson; Christopher M Rembold; Maria Rosvall; Tatjana Rundek; Jukka T Salonen; Matthias Sitzer; Coen D A Stehouwer; Jacqueline C Witteman; Karel G Moons; Michiel L Bots Journal: JAMA Date: 2012-08-22 Impact factor: 56.272
Authors: Guy De Backer; Ettore Ambrosioni; Knut Borch-Johnsen; Carlos Brotons; Renata Cifkova; Jean Dallongeville; Shah Ebrahim; Ole Faergeman; Ian Graham; Giuseppe Mancia; Volkert Manger Cats; Kristina Orth-Gomér; Joep Perk; Kalevi Pyörälä; José L Rodicio; Susana Sans; Vedat Sansoy; Udo Sechtem; Sigmund Silber; Troels Thomsen; David Wood Journal: Eur Heart J Date: 2003-09 Impact factor: 29.983
Authors: Ronald M A Henry; Piet J Kostense; Annemieke M W Spijkerman; Jacqueline M Dekker; Giel Nijpels; Robert J Heine; Otto Kamp; Nico Westerhof; Lex M Bouter; Coen D A Stehouwer Journal: Circulation Date: 2003-04-14 Impact factor: 29.690
Authors: Holger Hetterich; Axel Rominger; Lisa Walter; Maximilian Habs; Sarah Volpers; Marcus Hacker; Maximilian F Reiser; Peter Bartenstein; Tobias Saam Journal: Int J Cardiovasc Imaging Date: 2015-04-22 Impact factor: 2.357
Authors: Michiel L Bots; Karlijn A Groenewegen; Todd J Anderson; Annie R Britton; Jacqueline M Dekker; Gunnar Engström; Greg W Evans; Jacqueline de Graaf; Diederick E Grobbee; Bo Hedblad; Albert Hofman; Suzanne Holewijn; Ai Ikeda; Maryam Kavousi; Kazuo Kitagawa; Akihiko Kitamura; M Arfan Ikram; Eva M Lonn; Matthias W Lorenz; Ellisiv B Mathiesen; Giel Nijpels; Shuhei Okazaki; Daniel H O'Leary; Joseph F Polak; Jacqueline F Price; Christine Robertson; Christopher M Rembold; Maria Rosvall; Tatjana Rundek; Jukka T Salonen; Matthias Sitzer; Coen D A Stehouwer; Oscar H Franco; Sanne A E Peters; Hester M den Ruijter Journal: Hypertension Date: 2014-03-10 Impact factor: 10.190
Authors: Matthias W Lorenz; Jackie F Price; Christine Robertson; Michiel L Bots; Joseph F Polak; Holger Poppert; Maryam Kavousi; Marcus Dörr; Eva Stensland; Pierre Ducimetiere; Kimmo Ronkainen; Stefan Kiechl; Matthias Sitzer; Tatjana Rundek; Lars Lind; Jing Liu; Göran Bergström; Liliana Grigore; Lena Bokemark; Alfonsa Friera; David Yanez; Horst Bickel; M Arfan Ikram; Henry Völzke; Stein Harald Johnsen; Jean Philippe Empana; Tomi-Pekka Tuomainen; Peter Willeit; Helmuth Steinmetz; Moise Desvarieux; Wuxiang Xie; Caroline Schmidt; Giuseppe D Norata; Carmen Suarez; Dirk Sander; Albert Hofman; Ulf Schminke; Ellisiv Mathiesen; Matthieu Plichart; Jussi Kauhanen; Johann Willeit; Ralph L Sacco; Stela McLachlan; Dong Zhao; Björn Fagerberg; Alberico L Catapano; Rafael Gabriel; Oscar H Franco; Alpaslan Bülbül; Frank Scheckenbach; Anja Pflug; Lu Gao; Simon G Thompson Journal: Diabetes Care Date: 2015-07-15 Impact factor: 19.112